Verstegen NJM, Hagen RR, Kreher C, Kuijper LH, et al. T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination. J Neurol Neurosurg Psychiatry 2024 Mar 28:jnnp-2023-332224.
PMID: 38548324